AN2 Therapeutics, Inc. Operating Lease, Payments
AN2 Therapeutics, Inc. (ANTX) reported Operating Lease, Payments of $50.00 thousand for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:OperatingLeasePayments · last filed 2024-03-29
- AN2 Therapeutics, Inc. operating lease, payments for the quarter ending 2022-12-31 was $20.00K.
- AN2 Therapeutics, Inc. operating lease, payments for the quarter ending 2022-09-30 was $20.00K.
- AN2 Therapeutics, Inc. operating lease, payments for the quarter ending 2022-06-30 was $20.00K.
- AN2 Therapeutics, Inc. operating lease, payments for the quarter ending 2022-03-31 was $20.00K.
- AN2 Therapeutics, Inc. operating lease, payments for fiscal 2023 was $50.00K, a 37.50% decline from fiscal 2022.
- AN2 Therapeutics, Inc. operating lease, payments for fiscal 2022 was $80.00K.
| Period end | Operating Lease, Payments 3 month | Operating Lease, Payments 6 month | Operating Lease, Payments 9 month | Operating Lease, Payments 12 month |
|---|---|---|---|---|
| 2023-12-31 | $50.00K 10-K · filed 2024-03-29 | |||
| 2022-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-29 | $40.00K derived: sum of 2 quarters · filed 2024-03-29 | $60.00K derived: sum of 3 quarters · filed 2024-03-29 | $80.00K 10-K · filed 2024-03-29 |
| 2022-09-30 | $20.00K 10-Q · filed 2022-11-09 | $40.00K derived: sum of 2 quarters · filed 2022-11-09 | $60.00K 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $20.00K 10-Q · filed 2022-08-11 | $40.00K 10-Q · filed 2022-08-11 | ||
| 2022-03-31 | $20.00K 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Tonix Pharmaceuticals Holding Corp. (TNXP) | United States | $0.166B | -1.34 |
| Minerva Neurosciences, Inc. (NERV) | United States | $0.165B | -0.66 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| ADC Therapeutics SA (ADCT) | $0.163B | -1.39 |